Over-the-counter medications are primarily for self-medication, where the seller, such as a pharmacist, provides the necessary information and the consumer uses the medication at his or her own discretion based on the information provided. A Web survey was conducted from February 8 to 13, 2006, involving 500 men and women, ranging in age from 50 to 69 years, who had purchased over-the-counter medications for the common cold within the past 3 years. Upon consultation with and purchase of a cold medication from a pharmacist, 84.2％ of respondents reported``being asked my symptoms,'' and less frequently (12.3 21.3％) being asked about contraindications/careful administration. Most respondents (60.8％) when asked whether they conˆrmed``contraindications/careful administration'' responded negatively, stating they``occasionally do not conˆrm'' or``do not conˆrm.'' In addition, among men aged 50 69 years, it became clear that 6.0％ had experienced aggravation of prostatic hypertrophy symptoms after taking a cold medication. It is assumed that symptoms are usually conˆrmed upon the sale of over-the-counter medications, but the rate of conˆrming whether the consumer may need to consider contraindications/careful administration is low. Urinary retention is a preventable side eŠect because the conˆrmation prior to taking the medication can be made. Accordingly, some of those side eŠects can be avoided by ensuring the environment for conˆrming whether the individual corresponds tò`c ontraindications/careful administration'' before taking the medication.
INTRODUCTION
The attitude of the public toward medication has been changing in recent years. The idea of self-medication has become common due to the increasing number of people keenly interested in their own health together with the fact that the proportion of the elderly in the general population has been increasing at an extremely rapid pace, as have diseases associated with adult lifestyle habits. The World Health Organization (WHO) deˆnes self-medication as the selection of medication by individuals to treat selfrecognized illnesses or symptoms. Over-the-counter medications are sold primarily for self-medication, where the seller, such as a pharmacist, provides the necessary information and the consumer uses the medication at his or her own discretion based on the information provided. The methods for conˆrming proper usage when a consumer takes over-the-counter medications are``labeling on the outside of the box,''`p recautions for use,'' and``explanation on purchase.'' Consumer awareness regarding over-the-counter medication in Japan, such as the concept of selfmedication which involves an understanding of active ingredients, eŠects, and e‹cacy, and the selection of a single-ingredient medication that is eŠective for a speciˆc symptom, is not very high according to a market survey report conducted by the Japan External Trade Organization. 1) This problem also stems from the public mostly taking medications prescribed by a physician under the universal healthcare system, in which drug information, including that on side eŠects, is not su‹ciently provided on labeling. In addition, medications for the common cold, which are the most frequently purchased, are mostly complex preparations that are eŠective for multiple symptoms. 1) The antipyretic analgesic drugs, antihistamines, and antitussives and expectorants are combined in``multicold medication,'' which is a complex medication. Antihistamines are combined for the purpose of alleviating symptoms such as`r unny and stuŠy nose.'' Although the antihistamines are eŠective for acrinia of nasal secretion, because they have a degree of a‹nity to the muscarinic receptor structure, they are contraindicated for patients with lower obstructive uropathy such as prostatic hypertrophic patients, and glaucoma patients. 2) Chlorpheniramine maleate and diphenhydramine hydrochloride included in medications for the common cold are also used in ethical drugs; however, package inserts state that they are contraindicated for patients with lower obstructive uropathy such as prostatic hypertrophy, and for patients with glaucoma. On the other hand, the package inserts for many over-the-counter medications mention that individuals with dysuria should consult with a physician/ pharmacist before taking them. According to a study of 195 speciˆcations of nonprescription products by Kizu et al., 3) the contraindication information could not be accessed without opening the package for 87 speciˆcations and 61 products.
Therefore, in this study, we investigated the actual situation of purchasing``medications for the common cold'' primarily by examining``conˆrming the situation related to contraindications/careful administration'' for consumers who had taking overthe-counter medications for the common cold. Speciˆcally, prostatic hypertrophy is present in 44％ of Japanese men in their 50s and in 52％ of those in their 60s. 4) The side eŠects of cold medications which are aggravated by prostatic hypertrophy are preventable side eŠects because conˆrmation prior to taking the medication can be made. In addition, we studied the conditions underlying manifestations of``symptoms of aggravated prostatic hypertrophy.''
CONSUMERS AND METHODS
The consumers participating in this study were selected from the contract monitors of NTT Visual Communication Co., Ltd. They comprised 500 men and women, ranging from 50 to 69 years of age (men and women in their 50s and 60s, 125 subjects, respectively) who had purchased over-the-counter medications for the common cold within the past 3 years.
Survey Period A Web survey was conducted from February 8 to 13, 2006 .
Establishment of Survey Items
This study was conducted with consumers who had purchased common cold medications at a pharmacy or drugstore within the past 3 years.
Consultation Experience with a Pharmacist and Reason for Choosing to Have a Consultation (Q1, SQ1, Q2, and SQ2)
Consumers who had consulted with a pharmacist when purchasing their``cold medication'' were questioned in detail regarding the content of the consultation.``Contraindications/ careful administration'' were addressed in the questions,``Do you have any other health conditions?'' and``What types of health conditions have you experienced?'' Subsequently, preferences regarding consultation were surveyed using the three selections of``wanted to consult with a pharmacist,''``wanted to consult with someone, but the person did not need to be a pharmacist,'' and``did not want to consult with anyone.'' Those consumers who did not respond that they``wanted to consult with a pharmacist'' were then asked their reason for believing that it was not necessary for them to have a consultation.
Points of Attention and Confusing Issues when Selecting``Cold Medication'' and Conˆrmation of Individuals Subject to``Contraindications/Careful Administration'' (Q3, Q4, Q5, and SQ5)
Next, consumers were asked about what they paid attention to when selecting a cold medication. In this question, alternative responses including``trying to select a medication that is eŠective for my symptoms'' and`t rying to select a medication that is eŠective not only for my symptoms but also for other common cold symptoms as well (like the multicold medication)'' were oŠered to understand the tendency to select multicold medications. Furthermore, the alternative response``based on the image and impression of the pharmaceutical manufacturer, brand, and advertisement (commercial)'' was oŠered to determine the in‰uence of the media on their choice. The next question addressed problems experienced upon purchasing the``cold medication'' and centered on labeling on the box and package inserts, which are important sources of information for self-medication. In addition, a question addressing whether they had conrmed the situation related to``contraindications/ careful administration'' was asked, and individuals who had not conˆrmed the situation were asked for the reason.
Trends in Visiting the Outpatient Clinic upon Implementation of the Proposed Medical Service System Reform (Q6)
A question concerning the respon- dent's intention of visiting the outpatient clinic to receive a JPY 1000 exemption from copayment liability was asked for the purpose of predicting the trend if the outpatientˆxed-fee system comes into eŠect, as advocated in the Medical System Reform Implementation Proposal.
Occurrence of Side EŠects (Q7, Q8, Q9, and SQ9)
To clarify the occurrence of side eŠects after taking a cold medication, survey questions focused on the aggravation of prostatic hypertrophic symptoms, especially those related to anticholinergic eŠects, which are the side eŠects of antihistamines including those contained in many common cold medications. These questions were asked only of men. Subjective symptoms of prostatic hypertrophy were initially explained and then it was asked whether the corresponding symptoms had occurred. The explanation of subjective symptoms was made with reference to the International Prostate Symptom Score (IPSS) for the assessment of severity of prostatic hypertrophy. Then, after being questioned on their understanding that the side eŠects may aggravate prostatic hypertrophy, the respondents were asked a question to address their personal experience of prostatic hypertrophic aggravation after taking the cold medication, choosing from``experienced aggravation,''``experienced new symptom manifestation,''``experienced being unable to urinate,''``experienced no such symptoms,'' and``cannot remember.'' The types of medication being used when the symptoms manifested were also veriˆed.
Statistical Analysis
All results are described in terms of descriptive statistical values.
RESULTS

Respondent Characteristics
The characteristics of respondents are shown in Table 1 . The age and sex ratio was 1：1, and respondents resided in Tokyo (36.4％), Kanagawa (28.6％), Saitama (16.4％), and Chiba (18.6％). The occupational breakdown showed that many men were involved in self-owned businesses, while most women were housewives.
Consultation Experience with a Pharmacist and Reason for Choosing a Consultation when Purchasing a Cold Medication (Q1, SQ1, Q2, and SQ2)
The results regarding the consultation experience with a pharmacist and the items asked by the pharmacist during consultation are shown in Table 2 :`r espondents who had a consultation'' comprised 44.4％;``respondents who had a consultation, but did not know whether it was with a pharmacist'' comprised 17.6％; and``respondents who had no consul- tation'' comprised 38％. The items most frequently addressed by a pharmacist upon consultation and purchase of a cold medication was``being asked my symptoms'' (84.2％), and less frequently``being asked whether I had another health condition''
(21.3％) and``being asked the health condition(s) that I had suŠered up to that time'' (12.3％).
The results after``choosing to have a consultation with a pharmacist'' when purchasing a cold medication are shown in Table 3 . The percentage of subjects who wanted to consult with a pharmacist when purchasing a medication for the common cold was 58.8％, who responded that they``wanted to consult with a pharmacist if possible.'' Moreover, the reason why individuals believed it was not necessary to consult with a pharmacist was asked of those who answered``when I purchase something I would like to consult with someone, but it is not necessary for me to consult with a pharmacist'' or``I do not want to consult with anyone in particular.'' The most common response (39.3％) was``I always take the same medication, so I don't need a consultation,'' followed by (30.1％)``I think that over-the-counter medications should be safe.'' Points of Attention and Confusing Issues when Selecting``Cold Medication'' and Conˆrmation of Individuals Subject to``Contraindications/Careful Administration'' (Q3, Q4, and Q5)
The responses on the points paid attention to by consumers upon selecting a cold medication were, in order of frequency,``trying to select a medication that is eŠective for my symptoms'' (54.6％), followed by``how to take a medication'' (40.0％), and``trying to select a medication that is eŠective not only for my symptoms, but also for other common cold symptoms as well'' (36.4％) ( Table 4) . Responses for the problems consumers experienced upon selecting a``cold medication'' were``it is di‹cult to know the diŠer-ence between one product and another'' (49.4％), and``the cautionary statement cannot be read in detail without opening the package'' (34.2％) ( Table  4) . The response to the question on whether the consumer conˆrmed``contraindications/careful administration'' was the sum of those responding``occasionally do not conˆrm'' and``do not conˆrm'' (60.8％) ( Table 5) .
Trends in Visiting the Outpatient Clinic Based on Proposed Medical Service System Reform (Q6)
Regarding the trend in visiting the outpatient clinic after the proposed medical service system reform, 33.4％ of respondents stated that``it won't be any diŠerent than it is now,'' 52.6％ that``I suppose that trying treatment with over-the-counter medications might increase compared with the present,'' and 14.0％ that``I have no idea'' (data not shown).
Occurrence of Side EŠects (Q7, Q8, Q9, and SQ9), Circumstances Surrounding the Recognition of Side EŠects and the Experience of Side EŠect Manifesta- tion Regarding the item asking whether the individual had a symptom suggesting prostatic hypertrophy, 10.8％ of the 250 men respondents answered that``I have been diagnosed or am currently being diagnosed with it,'' and 37.6％ answered that``I have a suspicious symptom.'' Thus, fewer than 50％ of the respondents may have suspected prostatic hypertrophy (data not shown). Furthermore, when asked about the awareness of side eŠects, such as the potential for aggravation of``prostatic hypertrophy'' with over-the-counter cold medications, 3.2％ of respondents stated that``I am aware of the details,'' 21.2％ that``I have heard of it,'' and 75.6％ that``I don't know anything about it at all'' (data not shown). Among individuals who had experienced side eŠects, 70.2％ responded``I did not know at all'' about the side eŠects, including the aggravation of prostatic hypertrophy (Table 6 ). Furthermore, according to the results of questions on the occurrence of prostatic hypertrophic aggravation upon taking a cold medication, 6 .0％ responded that they had``experienced aggravation,''``experienced new symptom manifestation,'' or``experienced being unable to urinate.'' Those who had experienced urinary retention comprised 3.6％. Moreover, 46.7％ responded they had experienced urinary retention and answered the question,``Which type of cold medication caused such side eŠects?'' with a``multicold medication.''
DISCUSSION
According to the results of this study, although pharmacists or other pharmacy staŠ were asked about symptoms 84.2％ of the time during consultation, only 21.3％ of respondents had been asked,``Do you have any other health conditions?'', which corresponds with verifying the``contraindications/careful administration,'' and 12.3％ had been asked,`H ave you had other health condition?'' According to the report by Shiragami, 5) the rate of response by pharmacists regarding their explanation of eŠects and e‹cacy was 67.5％; whereas the response by pharmacists regarding their explanation of``cautions about age and health conditions'' for contraindications/careful administration was 30.9％. Therefore, it is assumed that symptoms are often conˆrmed upon the sale of over-the-counter medications, but the rate of conˆrming whether the consumer is relevant to the contraindications/careful administration is low.
In addition, in men aged 50 69 years, in this study 6.0％ had experienced aggravation of prostatic hypertrophy symptoms and 3.6％ had experienced urinary retention after taking a common cold medication. Oshima et al. reported that 6.6％ of individuals were in the``contraindication/careful administration'' category in their background study of 257 users of over-the-counter medication, 6 ) a very similar percen- tage to those respondents who reported experiencing prostatic hypertrophy aggravation in the present study. An increase in the size of the inner prostate gland occurs with aging in men over 50, and some develop clinical manifestations. In Japanese men, prostatic hypertrophy occurs in 44％ in their 50s, 52
％ in their 60s, and 63％ in their 70s. 4) Of the 250 men in this study, 48.4％ reported that they had been diagnosed with or had suspicious symptoms of prostatic hypertrophy, and approximately half of the men aged 50 to 69 years had or were suspected to have prostatic hypertrophy. Among the 250 men, 75.6％ responded that they did not know about the side eŠects, such as prostatic hypertrophic aggravation due to combination cold medications. The side eŠects of cold medications that aggravate prostatic hypertrophy symptoms are preventable, if conˆrmation prior to taking the medication can be made. Accordingly, it is necessary to determine whether an individual corresponds to thè`c ontraindications/careful administration'' before selling the medication.
This study found that 34.2％ of respondents in response to Q4,``Do you have problems in selecting a cold medication?'' answered that``I cannot read the cautionary statement in detail without opening the package,'' and 21％ responded that``I cannot tell whether I correspond to:`an individual who should not take the medication' or`an individual who should consult with a physician/pharmacist prior to taking the medication' from the labeling on the box.'' According to the study by Kizu et al., 3) of 195 speciˆca-tions of nonprescription products, the contraindication information could not be accessed without opening the package for 87 speciˆcations and 61 products. Otsuka et al. pointed out that the safety information in Japan is insu‹cient compared to that in the USA. 7, 8) It appears necessary to increase the safety information on the package so that the risks can be understood at the purchasing stage. This would be beneˆcial since 13.2％ of our respondents who did not read contraindications/careful administration said one reason was that``there was no detailed description on the package.'' When 15 persons who had experienced prostatic hypertrophic aggravation were which type of medication had been taken, 46.7％ answered that it was a multicold medication, 13.3％ that it was another type, and 40％ could not remember. Most over-thecounter cold medications are complex and eŠective for various symptoms. In addition, most products are combined with antihistamines, and there are few choices available for self-medication without taking an antihistamine. Two-hundred and ninety-nine multicold medications are in the Self-Medication DataBase of the Japan Self-Medication Industry. 9) Among them, antihistamines are contained in about 75％. According to a study of consumer advisors conducted by the Japan External Trade Organization, more than 60％ of individuals responded that they``did not know'' how to recognize complex and single-ingredient medications. 1) In addition, upon questioning whether one would select complex or single-ingredient medications after an introduction to the diŠerences between them and because almost all products for self-medication are complex medications, the majority responded with``it is better to select a single-ingredient medication that is eŠective for a speciˆc symptom,'' only 16％ responded that``it is better to take complex medications, because selecting medications is troublesome.'' In particular, among only those individuals who could not recognize single-ingredient medications,``the use of both single-ingredient medications and complex medications'' was 50％, and`t he use of the single-ingredient medications in a positive manner'' was 30％. As a result of the responses given, encouraging single-ingredient medication sales appears to be necessary.
According to our results, in``conˆrming contraindications / careful administration,'' which corresponds to``precautions,'' although 39.2％ of respondents said that they conˆrmed the contraindications/careful administration information, only 18.0％ said that they would conˆrm whether not it was appropriate for them to take a cold medication. Usami et al. reported that 17％ of their respondents read about``matters one should not do. '' 10) Even in the present study, among the 206 subjects who responded`o ccasionally do not conˆrm'' and``do not conˆrm'' for Q5, the reason for not conˆrming the precaution was``I haven't had any problem in particular with taking the drug, to date'' (59.2％), and``I think I do not correspond to these individuals because I haven't had any particular health problem'' (38.8％). However, 6 individuals had been diagnosed with prostatic hypertrophy, and 24 of the 59 men believed that they did not have a chronic health condition with suspicious symptoms of prostatic hypertrophy, although they had not been diagnosed as such. In a study in asthmatic patients by Watanabe et al., it was reported that approximately 70％ of patients had not been told about their asthma as an issue of caution when they sought diagnosis and purchased medications, and only half recognized the possibility that antipyretic analgesic drugs, such as aspirin, could induce asthma. 11) Consumer education is considered necessary to select appropriate drugs because 60％ of individuals are reported to stock multiple cold medication in the household. 5) For the question in this study regarding whether respondents wanted to consult a pharmacist when purchasing a cold medication, 58.8％ responded that they would like to do so if possible. Of note, 11 of the 15 who had experienced prostatic hypertrophic aggravation responded positively. The reason for not consulting a pharmacist was given by 39.3％ as``It is not necessary to have a consultation all of the time when I take the same medication,'' by 30.1％ as``I think that over-the-counter medications should be safe,'' and by 29.6％ as``I can generally understand by looking at the package label.'' Further, 13.6％ of respondents believed that``most pharmacists are inadequate for consultation.'' However, the possibility has been pointed out that pharmacists in Japan do not fulˆll their occupational function as specialists in the sale of over-the-counter medications. Sugawara et al. calculated the eŠect of switching to over-the-counter medication on medical care expenses using conjoint analysis, and found that there would be a 13％ decrease in such expenses without an in-depth explanation by a pharmacist and a 34.5％ decrease with an in-depth explanation. 12) Scar et al. reported that 7.1％ of problems were also preventable by employing the assistance of aˆnal-year pharmacy school student as a seller for over-the-counter medications. 13 ) Active participation should be expected from medication specialists.
This study involved a population of research company monitors in their 50s and 60s. Although there was a bias because all were company monitors, it is thought that this dose not signiˆcantly alter the results because it can be assumed that the prevalence of prostatic hypertrophy in the general population is greater than among the participants in this study due to the increasing number of senior citizens in Japanese society. Also, even though all were metropolitan area residents and the study involved a survey method conducted on the Internet, according to the Internet White Paper 2006, it is reported that the Internet penetration rate for households (the percentage of households in which there is an Internet user regardless of the location of use and connection apparatus) was 85.4％ 14) in Japan. Thus our results should still be representative of the general population.
The International Pharmaceutical Federation has published guidelines to clarify the role of the pharmacist, company, and physician in creating an environment for responsible self-medication, in which the importance of cooperation by all of the professionals surrounding consumers is mentioned. In the present study, 52.6％ of respondents stated that selfmedication opportunities would increase if the proposed reform of the medical-care system occurred. Therefore, in addition to the fact that pharmacists should become involved in a proactive way, it is necessary for consumers themselves to contribute to an environment conducive to determining the proper usage of over-the-counter drugs.
